BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 29174813)

  • 1. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
    Huang G; Zhao HR; Meng QQ; Zhang QJ; Dong JY; Zhu BQ; Li SS
    Eur J Med Chem; 2018 Jan; 143():166-181. PubMed ID: 29174813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
    Wang R; Zhang X; Song H; Zhou S; Li S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines.
    Zhang Q; Dong J; Cui J; Huang G; Meng Q; Li S
    Chem Pharm Bull (Tokyo); 2018; 66(6):612-619. PubMed ID: 29863062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
    Huang G; Dong JY; Zhang QJ; Meng QQ; Zhao HR; Zhu BQ; Li SS
    Eur J Med Chem; 2019 Mar; 165():160-171. PubMed ID: 30677614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
    Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
    Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel cytotoxic azanaphthoquinone annelated pyrrolo oximes.
    Shanab K; Pongprom N; Wulz E; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6091-5. PubMed ID: 17904839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
    Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel quinoline derivatives carrying nitrones/oximes nitric oxide donors: Design, synthesis, antiproliferative and caspase-3 activation activities.
    Abdelbaset MS; Abdel-Aziz M; Abuo-Rahma GEA; Abdelrahman MH; Ramadan M; Youssif BGM
    Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800270. PubMed ID: 30500087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives.
    Latif AD; Gonda T; Vágvölgyi M; Kúsz N; Kulmány Á; Ocsovszki I; Zomborszki ZP; Zupkó I; Hunyadi A
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents.
    Hisham M; Youssif BGM; Osman EEA; Hayallah AM; Abdel-Aziz M
    Eur J Med Chem; 2019 Aug; 176():117-128. PubMed ID: 31108261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel steroidal 5α,8α-epidioxyandrost-6-ene-3β-ol-17-(O-phenylacetamide)oxime derivatives as potential anticancer agents.
    Bu M; Cao T; Li H; Guo M; Yang BB; Zeng C; Zhou Y; Zhang N; Hu L
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3856-3861. PubMed ID: 28666736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-synthesis and anti-tumor activity of 5,8-O-dimethyl acylshikonin derivatives.
    Zhou W; Peng Y; Li SS
    Eur J Med Chem; 2010 Dec; 45(12):6005-11. PubMed ID: 20970893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel diosgenin derivatives containing 1,3,4-oxadiazole/thiadiazole moieties as potential antitumor agents: Design, synthesis and cytotoxic evaluation.
    Zhang J; Wang X; Yang J; Guo L; Wang X; Song B; Dong W; Wang W
    Eur J Med Chem; 2020 Jan; 186():111897. PubMed ID: 31761382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Cell Necroptosis and Apoptosis Induced by Shikonin via Receptor Interacting Protein Kinases in Estrogen Receptor Positive Breast Cancer Cell Line, MCF-7.
    Shahsavari Z; Karami-Tehrani F; Salami S
    Anticancer Agents Med Chem; 2018; 18(2):245-254. PubMed ID: 28933271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
    Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
    Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of novel bisindole derivatives bearing oximes moiety: identification of novel proapoptotic agents.
    Qu HE; Huang RZ; Yao GY; Li JL; Ye MY; Wang HS; Liu L
    Eur J Med Chem; 2015 May; 95():400-15. PubMed ID: 25841196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of anilide (dicarboxylic acid) shikonin esters as antitumor agents through targeting PI3K/Akt/mTOR signaling pathway.
    Ma Y; Yang X; Han H; Wen Z; Yang M; Zhang Y; Fu J; Wang X; Yin T; Lu G; Qi J; Lin H; Wang X; Yang Y
    Bioorg Chem; 2021 Jun; 111():104872. PubMed ID: 33838560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
    Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L
    Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.